- Tytuł:
- MPN-075 Efficacy and Safety of Add-on Parsaclisib to Ruxolitinib Therapy in Myelofibrosis Patients With Low Versus Higher Baseline Platelet Counts: A Subgroup Analysis of Data From a Phase 2 Study
- Autorzy:
- Źródło:
- In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S324-S324
Czasopismo naukowe